IL22 and steatosis: Recombinant IL-22 (rIL-22) reduces the expression of genes related to lipogenesis and promotes the expression of genes with antiapoptotic, antioxidant and prosurvival activities, thus relieving hepatocyte injury and steatosis, ameliorating insulin resistance, and modulating metabolic syndrome [26].